Studies from AD patients, patient-derived stem cell models, and human APOE4-expressing and APOE-deficient mouse models clearly demonstrated that APOE4 provokes neuroinflammation, impairs the cerebrovasculature, and exacerbates Aβ and tau pathology [64]. This evidence concerns the gene MAPT and Alzheimer disease.